877671-39-1

Basic information

• Product Name: tert-butyl (3-methoxy-4-nitrophenyl)carbamate
• Synonyms: tert-butyl (3-methoxy-4-nitrophenyl)carbamate
• CAS NO: 877671-39-1
• Molecular Weight: 268.269
• Mol File: 877671-39-1.mol

Chemical Properties

• CAS DataBase Reference: tert-butyl (3-methoxy-4-nitrophenyl)carbamate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl (3-methoxy-4-nitrophenyl)carbamate(877671-39-1)
• EPA Substance Registry System: tert-butyl (3-methoxy-4-nitrophenyl)carbamate(877671-39-1)

Safety Data

• Hazardous Substances Data: 877671-39-1(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
Tert-butyl (3-methoxy-4-nitrophenyl)carbamate is used as a precursor in the synthesis of various biologically active molecules for medicinal purposes. Its unique structure allows for the creation of new compounds with potential therapeutic applications.
Used in Research and Development:
In the realm of research and development, tert-butyl (3-methoxy-4-nitrophenyl)carbamate is employed as a key component in the design and synthesis of novel compounds aimed at advancing medicinal chemistry. Its reactivity and structural features make it a valuable asset in the discovery of new pharmaceutical agents.

Upstream product

• 60144-52-7 tert-butyl 3-methoxyphenylcarbamate 
• 5081-36-7 3-methoxy-4-nitrobenzoic acid 
• 75-65-0 tert-butyl alcohol 

Downstream Products

• 487065-22-5 N-(tert-butoxycarbonyl)-3-methoxy-1,4-phenylenediamine 

Relevant articles and documents

Visible-Light-Mediated Nitration of Protected Anilines

The photocatalytic nitration of protected anilines proceeds with riboflavin tetraacetate as an organic photoredox catalyst. Sodium nitrite serves as the NO2 source in this visible-light-driven room temperature reaction. Various nitroanilines are obtained in moderate to good yields without the addition of acid or stoichiometric oxidation agents. The catalytic cycle is closed by aerial oxygen as the terminal oxidant.

New dihydropteridione derivatives, process for their manufacture and their use as medicament

Disclosed are new dihydropteridinones of the formula (I) wherein the groups L, R1, R2, R3, R4 and R5 have the meanings provided herein, the isomers thereof, processes for preparing these dihydropteridinones and their use as pharmaceutical compositions.

DIHYDROPTERIDINONE DERIVATIVES, METHODS FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS

The invention relates to novel dihydropteridinones of general formula (I), in which the radicals L, R1, R2, R3, R4 and R5 have the meanings cited in the claims and description, to isomers thereof, methods for producing these dihydropteridinones, and to their use as medicaments.